Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multicenter validation of the magnetic resonance T2* technique for segmental and global quantification of myocardial iron.
Ramazzotti A, Pepe A, Positano V, Rossi G, De Marchi D, Brizi MG, Luciani A, Midiri M, Sallustio G, Valeri G, Caruso V, Centra M, Cianciulli P, De Sanctis V, Maggio A, Lombardi M. Ramazzotti A, et al. Among authors: cianciulli p. J Magn Reson Imaging. 2009 Jul;30(1):62-8. doi: 10.1002/jmri.21781. J Magn Reson Imaging. 2009. PMID: 19557847
Standardized T2* map of a normal human heart to correct T2* segmental artefacts; myocardial iron overload and fibrosis in thalassemia intermedia versus thalassemia major patients and electrocardiogram changes in thalassemia major patients.
Ramazzotti A, Pepe A, Positano V, Scattini B, Santarelli MF, Landini L, De Marchi D, Keilberg P, Derchi G, Formisano F, Pili M, Lai ME, Forni G, Filosa A, Prossomariti L, Capra M, Pitrolo L, Borgna-Pignatti C, Cianciulli P, Maggio A, Lombardi M. Ramazzotti A, et al. Among authors: cianciulli p. Hemoglobin. 2008;32(1-2):97-107. doi: 10.1080/03630260701879514. Hemoglobin. 2008. PMID: 18274987
Improved T2* assessment in liver iron overload by magnetic resonance imaging.
Positano V, Salani B, Pepe A, Santarelli MF, De Marchi D, Ramazzotti A, Favilli B, Cracolici E, Midiri M, Cianciulli P, Lombardi M, Landini L. Positano V, et al. Among authors: cianciulli p. Magn Reson Imaging. 2009 Feb;27(2):188-97. doi: 10.1016/j.mri.2008.06.004. Epub 2008 Jul 30. Magn Reson Imaging. 2009. PMID: 18667287
Cardiac and hepatic iron and ejection fraction in thalassemia major: multicentre prospective comparison of combined deferiprone and deferoxamine therapy against deferiprone or deferoxamine monotherapy.
Pepe A, Meloni A, Rossi G, Cuccia L, D'Ascola GD, Santodirocco M, Cianciulli P, Caruso V, Romeo MA, Filosa A, Pitrolo L, Putti MC, Peluso A, Campisi S, Missere M, Midiri M, Gulino L, Positano V, Lombardi M, Ricchi P. Pepe A, et al. Among authors: cianciulli p. J Cardiovasc Magn Reson. 2013 Jan 16;15(1):1. doi: 10.1186/1532-429X-15-1. J Cardiovasc Magn Reson. 2013. PMID: 23324167 Free PMC article.
Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging.
Pepe A, Meloni A, Capra M, Cianciulli P, Prossomariti L, Malaventura C, Putti MC, Lippi A, Romeo MA, Bisconte MG, Filosa A, Caruso V, Quarta A, Pitrolo L, Missere M, Midiri M, Rossi G, Positano V, Lombardi M, Maggio A. Pepe A, et al. Among authors: cianciulli p. Haematologica. 2011 Jan;96(1):41-7. doi: 10.3324/haematol.2009.019042. Epub 2010 Sep 30. Haematologica. 2011. PMID: 20884710 Free PMC article.
Guideline recommendations for heart complications in thalassemia major.
Cogliandro T, Derchi G, Mancuso L, Mayer MC, Pannone B, Pepe A, Pili M, Bina P, Cianciulli P, De Sanctis V, Maggio A; Society for the Study of Thalassemia and Hemoglobinopathies (SoSTE). Cogliandro T, et al. Among authors: cianciulli p. J Cardiovasc Med (Hagerstown). 2008 May;9(5):515-25. doi: 10.2459/JCM.0b013e3282f20847. J Cardiovasc Med (Hagerstown). 2008. PMID: 18404006
Long-term use of deferiprone significantly enhances left-ventricular ejection function in thalassemia major patients.
Maggio A, Vitrano A, Lucania G, Capra M, Cuccia L, Gagliardotto F, Pitrolo L, Prossomariti L, Filosa A, Caruso V, Gerardi C, Campisi S, Cianciulli P, Rizzo M, D'Ascola G, Ciancio A, Di Maggio R, Calvaruso G, Pantalone GR, Rigano P. Maggio A, et al. Among authors: cianciulli p. Am J Hematol. 2012 Jul;87(7):732-3. doi: 10.1002/ajh.23219. Epub 2012 May 24. Am J Hematol. 2012. PMID: 22622672 Free article. Clinical Trial.
Increased survival and reversion of iron-induced cardiac disease in patients with thalassemia major receiving intensive combined chelation therapy as compared to desferoxamine alone.
Lai ME, Grady RW, Vacquer S, Pepe A, Carta MP, Bina P, Sau F, Cianciulli P, Maggio A, Galanello R, Farci P. Lai ME, et al. Among authors: cianciulli p. Blood Cells Mol Dis. 2010 Aug 15;45(2):136-9. doi: 10.1016/j.bcmd.2010.05.005. Epub 2010 Jun 17. Blood Cells Mol Dis. 2010. PMID: 20678715
Safety of cardiovascular magnetic resonance gadolinium chelates contrast agents in patients with hemoglobinopathies.
Meloni A, Favilli B, Positano V, Cianciulli P, Filosa A, Quarta A, D'Ascola D, Restaino G, Lombardi M, Pepe A. Meloni A, et al. Among authors: cianciulli p. Haematologica. 2009 Nov;94(11):1625-7. doi: 10.3324/haematol.2009.010181. Epub 2009 Aug 27. Haematologica. 2009. PMID: 19713229 Free PMC article. Clinical Trial. No abstract available.
Hepatocellular carcinoma in thalassaemia: an update of the Italian Registry.
Borgna-Pignatti C, Garani MC, Forni GL, Cappellini MD, Cassinerio E, Fidone C, Spadola V, Maggio A, Restivo Pantalone G, Piga A, Longo F, Gamberini MR, Ricchi P, Costantini S, D'Ascola D, Cianciulli P, Lai ME, Carta MP, Ciancio A, Cavalli P, Putti MC, Barella S, Amendola G, Campisi S, Capra M, Caruso V, Colletta G, Volpato S. Borgna-Pignatti C, et al. Among authors: cianciulli p. Br J Haematol. 2014 Oct;167(1):121-6. doi: 10.1111/bjh.13009. Epub 2014 Jul 3. Br J Haematol. 2014. PMID: 24992281 Free article.
83 results